56 results
425
EX-10.2
CYTH
Cyclo Therapeutics Inc - Ordinary Shares
11 Jun 24
Business combination disclosure
3:19pm
payment (whether in cash, securities or other property or assets) on account of the redemption, repurchase, defeasance, sinking fund or other retirement … of principal or premium, if any, or interest, fees or other charges on or with respect to, and any redemption, purchase, retirement, defeasance, sinking
8-K
EX-10.2
CYTH
Cyclo Therapeutics Inc - Ordinary Shares
11 Jun 24
Entry into a Material Definitive Agreement
3:19pm
payment (whether in cash, securities or other property or assets) on account of the redemption, repurchase, defeasance, sinking fund or other retirement … of principal or premium, if any, or interest, fees or other charges on or with respect to, and any redemption, purchase, retirement, defeasance, sinking
8-K
EX-10.1
CYTH
Cyclo Therapeutics Inc - Ordinary Shares
20 Oct 23
Unregistered Sales of Equity Securities
2:19pm
, retirement, supplemental retirement or other employee benefit plan, program, agreement or arrangement, whether written or unwritten, formal or informal … that do not exceed, individually or in the aggregate, $300 per month per any particular person. “ERISA” means the Employee Retirement Income Security Act
425
EX-2.1
5tkq6
21 Sep 23
Business combination disclosure
4:28pm
8-K
EX-2.1
9u4aj9vlpqckzci
21 Sep 23
Cyclo Therapeutics, Inc. and Applied Molecular Transport Inc. Enter into a Definitive Merger Agreement
4:28pm
8-K
EX-10.1
xk7 cxtf8uoz
5 Jun 23
Entry into a Material Definitive Agreement
9:22am
8-K
EX-10.1
6uwk790
4 May 23
Unregistered Sales of Equity Securities
3:42pm
8-K
EX-10.1
vsn6f5 0399sghxq1
24 Apr 23
Unregistered Sales of Equity Securities
9:24am
8-K
EX-10.1
oqpvld fmib
16 Aug 21
Entry into a Material Definitive Agreement
4:52pm
8-K
EX-10.1
xbyk1dq88z4 uq4t
25 Jun 21
Departure of Directors or Certain Officers
4:03pm
8-K
EX-10.1
cv9gj1
11 Dec 20
Cyclo Therapeutics Announces Pricing of $12.5 Million Public Offering
4:02pm